Showing results (11-20 of 160) with videos related to
Sort By:
Pageof 16
Annals of the New York Academy of Sciences|November 1, 2003
Treatment principles in the management of autoimmune myasthenia gravisDavid P Richman, Mark A AgiusCancer Immunology Research|January 14, 2014
Role of crosslinking for agonistic CD40 monoclonal antibodies as immune therapy of cancerLee P Richman, Robert H VonderheideJournal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteriaC M Gomez, D P RichmanJournal of Immunology (Baltimore, Md. : 1950)|July 1, 1985
Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravisC M Gomez, D P RichmanBiochimica Et Biophysica Acta|December 9, 2014
Myasthenia gravis and related disorders: Pathology and molecular pathogenesisJames C Ha, David P RichmanProceedings of the National Academy of Sciences of the United States of America|September 1, 1979
Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytesD P Richman, B G ArnasonSeminars in Neurology|June 1, 1994
Myasthenia gravis: pathogenesis and treatmentD P Richman, M A AgiusJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1986
Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibodyM A Agius, D P RichmanProceedings of the National Academy of Sciences of the United States of America|July 1, 1983
Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myastheniaC M Gomez, D P RichmanPageof 16